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Methods: Thirty AD patients, 41 mild cognitive impairment (MCI) patients, and 38 healthy controls
(HCs) underwent cerebral magnetic resonance imaging (with an automated segmentation protocol for
the volumetric analysis of hippocampal subfields) and a test of immediate and delayed recall of a 15-
word list.
Results: The volumes of the presubiculum and subiculum presented the most remarkable reduction
in the patient’s groups. In the MCI group, only the volumes of presubiculum and subiculum predicted
performance on the memory tests. In AD patients, the volumes of all hippocampal subfields (with the
notable exception of the CA1) predicted memory scores.
Conclusions: Our data point to a prevalent atrophy of the presubicular-subicular complex from the
early phases of AD. This finding is consistent with neuropathological observations in AD patients and
probably reflects the severe degeneration of the perforant pathway while penetrating the hippocam-
pus through the subicular field in its course from the entorhinal cortex to the dentate gyrus.
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Neuropathological changes in patients with Alzheimer’s
disease (AD) typically affect the hippocampal formation
very early [1,2]. Therefore, neuroradiological indexes of
hippocampal atrophy [3,4] and, consistent with the well-
known role of the hippocampus in human declarative mem-
ory [5], episodic memory deficits [6,7] are among the most
powerful diagnostic indexes of AD from the very early
phases, corresponding to the clinical condition of amnestic
mild cognitive impairment (MCI).author. Tel.: 139-06-51501517; Fax: 139-06-
emolab@hsantalucia.it
16/j.dadm.2014.12.001
e Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).The hippocampus is not, however, a unitary anatomical
formation. Several subfields have been identified, which can
be differentiated on both histological grounds [2,8] and
according to their functional role in memory encoding and
retrieval [9,10]. There is no consensus about which
subfields become atrophic earliest in the disease course or
which neuropathological change is primarily implicated in
volume reduction. According to some authors, neuronal loss
is the main cause of atrophy. However, the three studies that
provided neuronal counts in the hippocampal subfields of
patients with AD report discrepant data. West et al. [11,12]
found the most striking AD-related neuronal loss at the level
of the CA1 subfield, whereas Simic et al. [13] reported a
reduced number of neurons in the subiculum and dentate gy-
rus ofADpatients but not in other subfields. On the other side,imer’s Association. This is an open access article under the CC BY-NC-ND
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regional volume reduction of the hippocampus inAD. Indeed,
R€ossler et al. [14] found a very weak correlation between the
observed volume reduction and neuronal loss in the overall
hippocampus of AD patients, and Mizutani and Kasahara
[15,16] found that hippocampal atrophy in AD was mainly
caused by degeneration of the stratum lacunosum-radiatum,
which contains the perforant pathway that originates in the en-
torhinal cortex, rather than neuronal loss in the pyramidal
layer of the hippocampus.
The aims of this cross-sectional study were to delineate
the in vivo progression of atrophy in the main subfields of
the hippocampus in patients diagnosed with either MCI or
AD, and to determine whether atrophy in one or more spe-
cific hippocampal subfields best predict severity of episodic
memory impairment.2. Materials and methods
2.1. Subjects
A cohort of 109 individuals, 30 with a diagnosis of prob-
able AD, 41 with diagnostic characteristics of single-domain
amnestic MCI, and 38 healthy matched controls (HC), were
enrolled in this study. AD and MCI patients were consecu-
tively recruited from the specialist dementia clinics of Santa
Lucia Foundation (Rome, Italy).
HCswere recruited frompatients’ relatives or through local
advertisements. None of them showed cognitive problems or
evidence of cognitive deficits on neuropsychological testing.
Patients with AD met the clinical criteria for Alzheimer’s
dementia established by the National Institute on Aging and
the Alzheimer’s Association [17].
Diagnosis of single-domain amnestic MCI was made ac-
cording to established criteria [18] by trained neurologists.
Inclusion criteria were as follows: (1) subjective memory
impairment confirmed by a pathological score on at leastTable 1
Number of females and males (F/M) and mean (and standard deviation) of other
participants
Groups AD (n 5 30) MCI (n 5 41
F/M 16/14 16/25
Age 71.2 (7.3) 70.6 (6.8)
Years of formal education 8.4 (4.1)*,y 11.7 (4.1)
MMSE (adjusted score) 19.7 (3.8)*,y 26.3 (2.3)*
15-Word list test
Immediate recall 18.3 (9.4)*,y 26.6 (6.2)*
Delayed recall 1.5 (2.7)*,y 3.3 (2.7)*
APOE, n (%) AD (n 5 12) MCI (n 5 34
APOE 32/ 3 0 (0) 1 (3)
APOE 3 / 3 10 (83) 20 (59)
APOE 3 / 34 2 (17) 13 (38)
Abbreviations: AD, Alzheimer’s disease; MCI, mild cognitive impairment; HC
*Significantly less than in the HC group.
ySignificantly less than in the MCI group.one memory test of the neuropsychological battery; (2)
nonfulfillment of the criteria for dementia according to the
recommendations of the National Institute on Aging-Alz-
heimer’s Association work groups [17]; (3) preserved gen-
eral cognitive functions as confirmed by normal scores on
the Mini-Mental State Examination (MMSE) (normality
cutoff score, 24 [19]) and on tests of the neuropsychological
battery; (4) no or very mild impact of the memory deficit on
the subject’s activities, as confirmed by a normal score on the
instrumental activities of daily living and by a total Clinical
Dementia Rating (CDR) score 5 0.5; (5) lack of any evi-
dence of neurological or systemic pathology able to induce
memory disorders; (6) brain magnetic resonance imaging
(MRI) negative for focal lesions (minimal diffuse changes
or minimal lacunar lesions of white matter were admitted)
[20]; and (6) absence of moderate to severe depression
and/or anxiety, as confirmed by scores on Beck’s Depression
Inventory and the Hamilton Anxiety Rating scale (14 was
the highest acceptable score for both scales). Finally, for a
subsample of 46 patients (12 AD and 34 MCI patients),
the investigation of APOE ε4 allele frequency was carried
out, whereas for the HCs, no genetic data were available.
The principal demographic and clinical characteristics of
the studied subjects are summarized in Table 1.
After the procedures were explained to them, the subjects
gave theirwritten informed consent in a protocol approved by
the Joint Ethics Committee of the Fondazione Santa Lucia.2.2. Neuropsychological examination
Consistent with the hypothesis of the study, two declara-
tivememory testswere selected from the comprehensiveneu-
ropsychological battery administered to all participants: the
immediate and the 15-minute delayed recall of a 15-word list.
In the 15-word list learning test [21], the examiner reads 15
words aloud (at a rate of 1 word/s) five times; immediatelydemographic, clinical, and genetic characteristics of the three groups of
) HC (n 5 38) Chi-square P
22/19 1.7 .44
F2,106 (df)
69.7 (4.4) 0.5 .61
11.4 (4.3) 6.3 .003
27.2 (1.7) 102.0 .0001
42.7 (8.3) 78.5 .0001
9.0 (2.8) 72.8 .0001
)
—
—
—
, healthy control; MMSE, Mini-Mental State Examination.
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words as possible in any order (immediate recall, score range:
0–75). After a 15-minute interval, the patient is asked to recall
asmanywords as possible (delayed recall, score range: 0–15).
The neuropsychological screening battery included tests
of logical reasoning (Raven’s Coloured ProgressiveMatrices
[21]), language (SentenceConstruction [21]), selective atten-
tion and resistance to interference (Stroop test [22]), concept
formation and shifting (ModifiedCard SortingTest [23]), and
constructional praxis and visuospatial abilities (copy of the
Rey-Osterrieth Complex Figure Test [24]).
2.3. MRI protocol
Participants underwent an imaging protocol which
included three-dimensional (3D) T1-weighted, T2-
weighted, and FLAIR sequences, using a 3-T Allegra MR
imager (Siemens, Erlangen, Germany) with a standard quad-
rature head coil. Whole-brain T1-weighted images were ob-
tained in the sagittal plane using a modified driven
equilibrium Fourier transform sequence (echo time/repeti-
tion time 5 2.4/7.92 ms, flip angle 15, voxel size
1! 1! 1 mm3).
The hippocampal segmentation was carried out by using
two successive methods. The whole hippocampus was
initially segmented by completing the FreeSurfer image anal-
ysis pipeline (Martinos Center for Biomedical Imaging, Bos-
ton, MA, USA) [25]. In brief, the processing relevant to this
work includes removal of nonbrain tissue by using a hybrid
watershed/surface deformation procedure [26], automated
Talairach transformation, and segmentation of the subcortical
white matter and deep gray matter volumetric structures. In
subjects with substantial anatomical differences with respect
to the template, for example, enlarged ventricles, the resulting
segmentation of the subcortical structures was improved by a
pairwise registration of their images to training images [27].
Next, segmentation of the hippocampus into its respective
subfields was performed by using Bayesian inference and a
previously described statistical model of the medial temporal
lobe [28]. The Dice overlap measures between manual and
automated segmentation methods were approximately 0.7
for all the substructures [28]. We focused on the volume of
the CA1, CA2/3, CA4/dentate gyrus, presubiculum, and sub-
iculum and excluded from the analyses the fimbria (which is a
white matter region), hippocampal fissure, and the final
portion of the hippocampal tail, which is not subdividable in
anyof the subfields. Total hippocampal volumewas computed
by summing relative volumes of the CA1, CA2/3, CA4/den-
tate gyrus, presubiculum, subiculum, and hippocampal tail.
2.4. Statistical methods
For statistical analysis, volumes of the left and right hippo-
campus and volumes of the left and right individual subfields of
each subject were averaged. Chi-square test for binomial vari-
ables and one-way analyses of variance (ANOVAs) for discrete
variables were used to compare the demographic characteris-tics of the three groups of participants. One-way analyses of
covariance (ANCOVAs)with years of formal education as a co-
variate were used to compare participants’ performance scores
on theMMSE andmemory tests and on hippocampal volumes.
When the group factor was significant, least significant differ-
ence post hoc tests were performed to qualify the main effect.
A two-wayANCOVAwith the group (ADvs.MCI) as between
factor and hippocampal subfield (CA1 vs. CA2-3 vs. CA4-DG
vs. presubiculum vs. subiculum) as within factor with years of
formal education as a covariate was performed to directly
compare the rate of volumedecrease of individual hippocampal
subfields among patients. Because the absolute volume of the
hippocampal subfields differed greatly, standardized z values
(calculated over the mean and standard deviation of the HC
group) were used as dependent variable. To evaluate the accu-
racy of hippocampal subfield volumes and of the overall hippo-
campal volume in assigning participants to their own group,
receiver operating characteristic (ROC) analyses were per-
formed. Finally, a number of partial correlation coefficients
were calculated between hippocampal volumes and memory
measures, controlling for years of formal education separately
for the three groups of participants.3. Results
3.1. Demographic and clinical characteristics
As can be seen in Table 1, the three groups (AD,MCI, and
HC) did not differ for sex distribution or age. Instead, they
differed for years of formal education, with AD patients
significantly less educated than MCI and HC participants.
The three groups also differed for the mean MMSE adjusted
score. Indeed, AD patients scored worse than the other two
groups and patients with MCI scored worse than HCs.
Finally, as for APOE genotypes, the 34 allele was present
in 17% of AD patients and in 38% of MCI patients who un-
derwent the genetic investigation.
3.2. Memory performance
Average performance scores of the three groups of partic-
ipants on the 15-word learning list test with relative statisti-
cal comparisons are reported in Table 1. The three groups
differed on both the immediate and delayed recall test,
with AD patients scoring worse than MCI patients who, in
turn, scored worse than HCs.
3.3. Hippocampal subfields
Table 2 reports volumes of different hippocampal sub-
fields and of the overall hippocampus in the three groups
of participants with relative group comparisons. One-way
ANOVAs documented that, with the exception of CA1, the
volume of all the other subfields, as well as of the entire hip-
pocampus, significantly differed among groups. Post hoc an-
alyses documented that although both groups of patients
significantly differed from HCs for volumes of the CA2-3,
Table 2
Mean volumes (and SD) of hippocampal subfields in the three groups of participants
Groups HC (n 5 38), volume (mm3) MCI (n 5 41), volume (mm3) AD (n 5 30), volume (mm3) F2,106 (df) P
CA1 305.2 (41.4) 288.0 (52.4) 283.6 (60.5) 1.4 .25
CA2-3 841.1 (125.8) 773.7 (160.4)* 723.3 (164.8)** 4.6 .01
CA4-DG 478.6 (69.5) 430.5 (93.4)* 393.7 (93.8)** 7.4 .0009
Presubiculum 411.4 (59.2) 355.3 (73.9)** 316.2 (70.1)**,*** 15.5 .0001
Subiculum 534.0 (67.1) 472.3 (100.0)** 425.1 (100.5)**,*** 11.5 .0001
Overall hippocampus 2980.2 (390.4) 2686.8 (528.6)* 2475.2 (535.5)** 8.3 .0004
Abbreviations: SD, standard deviation; HC, healthy control; MCI, mild cognitive impairment; AD, Alzheimer’s disease.
*P , .05 with respect to HCs.
**P , .01 with respect to HCs.
***P , .05 with respect to MCI patients.
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pus, patients with AD had reduced volumes of the presubic-
ulum and subiculum with respect to MCI patients.
Fig. 1 shows standardized z values of hippocampal sub-
field volumes in the two groups of patients. The two-way
ANOVA documented a nonsignificant main effect of the
group (F5 2.0; P5 .17) but highly significant effects of hip-
pocampal subfield (F5 35.0; P, .001) and of the group!
hippocampal subfield interaction (F 5 4.2; P 5 .002). In
particular, the significant effect of the hippocampal subfield
was due to a volume reduction (with respect to HCs) that was
minimal in the CA1 subfield, progressively larger in the
CA2-3 and CA4-DG subfields, and maximal in the presubic-
ulum and subiculum (all comparisons highly significant at
the least significant difference test, with the exception of
the presubiculum vs. subiculum,P5 .94). Instead, the signif-
icant group! hippocampal subfield interaction reflected the
nonhomogeneous volume decrease in the AD with respect to
theMCI group across the different subfields. Indeed, planned
comparisons confirmed a nonsignificant difference in vol-
ume reduction in the CA1 (P 5 .74), CA2-3 (P 5 .20), and
CA4-DG (P 5 .11) subfields but a significantly larger vol-
ume decrease in the AD than in the MCI group in the presu-
biculum (P 5 .02) and subiculum (P 5 .05).Fig. 1. Subfield volumes in theMCI and AD samples. The figure shows a represent
reconstruction (B), and the graph showing standardized z values of subfields volum
cognitive impairment; AD, Alzheimer’s disease.3.4. Discriminative power of hippocampal subfield volume
Table 3 reports the results of the ROC analyses for each
hippocampal subfield volume and for the overall hippocam-
pal volume discriminating the three groups of participants.
In all cases, the presubiculum produced the largest area un-
der the curve and the highest diagnostic sensitivity/speci-
ficity values, followed by the subiculum, the overall
hippocampal volume, the CA4-DG, CA3-DG, and finally,
the CA1 subfield. Volumes of all subfields and total hippo-
campal volume discriminated AD patients and HCs at a sig-
nificant level; overall hippocampal volume and volume of all
subfields, with the exception of CA1, discriminated signifi-
cantly between MCI patients and HCs; only the presubicu-
lum and subiculum subfield volumes significantly
discriminated AD from MCI patients.3.5. Correlation of hippocampal subfield volumes with
memory performance
Table 4 reports the correlation matrices of the hippocam-
pal subfield volumes with performance scores on memory
tests separately for patients with AD, patients with MCI,
and HCs.ative subfield segmentation of the left hippocampus of one subject (A), its 3D
es in the two samples (C). Sub, subiculum; PreSub, presubiculum;MCI, mild
Table 3
Results of the ROC analyses discriminating the group membership of participating individuals
Groups
HC vs. MCI MCI vs. AD HC vs. AD
AUC Sens. Spec. AUC Sens. Spec. AUC Sens. Spec.
CA1 0.60 0.61 0.59 0.54 0.70 0.50 0.65* 0.76 0.60
CA2-3 0.64* 0.66 0.61 0.59 0.59 0.55 0.72** 0.74 0.70
CA4-DG 0.68** 0.82 0.56 0.60 0.70 0.50 0.75** 0.71 0.73
Presubiculum 0.73** 0.79 0.61 0.65* 0.71 0.60 0.84** 0.82 0.83
Subiculum 0.71** 0.79 0.59 0.64* 0.68 0.57 0.81** 0.79 0.73
Overall hippocampus 0.69** 0.74 0.61 0.62 0.71 0.47 0.77** 0.79 0.70
Abbreviations: ROC, receiver operating characteristic; HC, healthy control; MCI, mild cognitive impairment; AD, Alzheimer’s disease; AUC, area under the
curve; Sens., diagnostic sensitivity; Spec., diagnostic specificity.
*P , .05.
**P , .01.
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were negative, in the AD and MCI groups, all correlation co-
efficients were positive, indicating that in these patients,
reduced anatomical volumes were consistently associated
with reduced memory performance. In the HC group, no cor-
relation coefficient was significant. Conversely, in the AD
group, several subfields and the overall hippocampus corre-
lated with memory scores. Notably, the only subfield that
did not show any significant correlation with verbal memory
measures was the CA1. In theMCI group, the only significant
correlations involved the presubiculum, subiculum, and over-
all hippocampus.4. Discussion
Results of the present study document progressive hippo-
campal atrophy in the different phases of AD that is not ho-
mogeneous across the various subfields. The CA1 subfield
was the one least involved in the AD-related atrophy. Its
size did not significantly differ in HCs, patients in the initial
phases of the Alzheimer’s degeneration, and patients with
fully developed AD. The CA2-3 and CA4-DG subfields pre-
sented atrophic changes that remained substantially stable
during the progression of AD pathology. Indeed, CA2 and
CA3 volumes were significantly smaller in the AD and
MCI groups with respect to the HC group but did not signif-
icantly differ between the patients’ groups. Finally, atrophicTable 4
Correlation matrices (Pearson’s r) of anatomical volumes and performance scores
Groups CA1 CA2-CA3 CA4-DG
AD patients
Word-list immediate recall 0.25 0.41* 0.42*
Word-list delayed recall 0.34 0.55** 0.58*
MCI patients
Word-list immediate recall 0.15 0.25 0.30
Word-list delayed recall 0.08 0.15 0.21
Healthy participants
Word-list immediate recall 20.09 20.04 0.00
Word-list delayed recall 20.19 20.06 20.07
Abbreviations: AD, Alzheimer’s disease; MCI, mild cognitive impairment.
*P , .05
**P , .01.changes in the presubiculum and subiculum progressively
worsened passing from the MCI to the AD group. As a mat-
ter of fact, not only did the volumes of these two structures
present the most remarkable reduction in the MCI and AD
groups with respect to the HC group, but they were also
the only ones that showed a significantly larger reduction
in the AD than in the MCI group.
Supporting the view that the progression of atrophy was
not homogeneous across the various hippocampal subfields,
the volumes of the presubiculum and subiculum best discrim-
inated the correct group membership of the individual partic-
ipants, followed by the CA4-DG, CA2-3, and finally, the
CA1 subfield. This was true both when we considered HCs
with respect to individuals in the two patients’ groups and
when we contrasted MCI versus AD patients.
The correlation pattern between anatomical volumes and
memory scores depended greatly on the pattern of hippo-
campal atrophy. Indeed, hippocampal subfield volumes
were significantly associated with performance scores on
the verbal episodic memory tests to the extent that they
were significantly reduced. Therefore, no significant associ-
ation between anatomical volumes and memory perfor-
mance was found in the HC group, whereas in the MCI
group, only the volumes of the presubiculum and subiculum
were positively associated with performance on the mem-
ory tests; finally, in AD patients, the volumes of all hippo-
campal subfields (with the notable exception of the CA1)on memory tests in patients with AD, MCI, and healthy participants
Presubiculum Subiculum Overall hippocampus
0.30 0.37* 0.40*
* 0.45* 0.53** 0.55**
0.32* 0.35* 0.33*
0.28 0.26 0.25
0.16 20.01 0.03
0.05 20.13 20.06
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In other words, regional hippocampal atrophy seems to be a
reliable indicator of memory functioning.
Our finding of a particularly severe volume reduction of the
subicular complex inAD is consistent with the neuropatholog-
ical observations made by Mizutani and Kasahara [15,16].
These authors investigating an autoptical series of AD
patients reported disproportionate atrophy in the subicular
complex with respect to Ammon’s horn fields (CA1, 2, 3,
and 4) and the dentate gyrus. They attributed the particularly
severe volume loss of these structures to isomorphic
fibrillary gliosis resulting from early and severe degeneration
of the perforant pathway while penetrating the hippocampus
through the subicular field, in its course from the entorhinal
cortex to the dentate gyrus. Mizutani and Kasahara [15] also
noted that the atrophic subiculum showedmarked loss of pyra-
midal neurons, whereas the hippocampus proper showed only
a slight loss of neurons. Both degeneration of the perforant
pathway and loss of pyramidal neurons would account for
our finding that subicular volume predicts the severity of the
verbalmemorydeficit inADpatients. Indeed, according toHy-
man et al. [29,30], the episodic memory deficit in AD patients
results from the anatomical and functional segregation of the
hippocampus from associative sensory inputs due to
degeneration of the perforant pathway. On the other side, the
neuronal loss in the subicular field [13,16] further compro-
mises the anatomical and functional communication of the
hippocampus with extrahippocampal connected regions.
Previous neuroimaging studies obtained contrasting data
regarding the pattern of hippocampal subfield atrophy in AD
patients. As for patients with fully developed AD, all studies
agree that the subiculum and the presubiculum show atro-
phic changes but differ as to the pattern of the volume reduc-
tion in Ammon’s horn subfields. Normal volume of the CA1
subfield was reported by Lim et al. [31], who used the same
automated segmentation protocol used in the present study,
and by Kerchner et al. [32], who inferred volume by
measuring the thickness of the CA1 subfield; both of the
aforementioned studies included patients whose disease
severity was similar to that of our patients (as indicated by
MMSE and CDR scores). Instead, the CA1 subfield was
found significantly atrophic in a study that used the same
automated method as ours and included patients with similar
dementia severity [33] and in studies that used a procedure
involving manual segmentation of hippocampal subfields
[34,35] or based on 3D surface reconstruction and shape
analysis of the hippocampi [36,37], irrespective of the
dementia severity of the included patients. Conversely, the
volume of the CA3 and CA4 subfields was found in the
normal range in most of the studies that used manual
segmentation [34,35] and 3D surface reconstruction and
shape analysis [36] but was invariably atrophic in studies
based on automated segmentation procedures [31,33].
Analogous literature on individuals with MCI is still more
controversial, with discrepant data resulting from adoption
of the same subfield segmentation procedure. Thus, forexample, the volume of the subiculum was reported to be
normal in MCI in a study that relied on manual
segmentation [35] and in another study that used an auto-
mated segmentation method [38] but was significantly
reduced in two other studies that also used a method of
manual [39] or automated segmentation [40].
There are several complementary explanations of these
contrasting data (see, for a detailed discussion, [33,35]).
Probably, the most critical issues regard the diagnostic
criteria adopted in sample selection and the reliability of the
segmentation techniques used for discriminating between
individual hippocampal subfields. Regarding the first issue,
inconsistencies might be due to the dementia severity in the
group of AD patients and the criteria adopted for defining
MCI. It seems quite obvious that both the dementia severity
in AD patients and the pattern of cognitive deficits in MCI
patients (only amnestic, amnestic plus other domains, or not
amnestic at all [41]) have a great impact on the expected
pattern of hippocampal regional atrophy. We selected rela-
tively large groups of patients with AD and MCI with the
aimof investigating the progressionof regional atrophy across
different stages of the disease. All the AD patients included
here were in the mild phase of the disease, and in recruiting
MCI patients, we adhered closely to diagnostic criteria for
single-domain amnestic MCI [18]. The fact that the MCI pa-
tients exhibited a regional pattern of hippocampal atrophy that
was qualitatively similar (even though less severe) to that of
fully developed AD patients is consistent with the hypothesis
that the single-domain amnestic profile ofMCI is the onemost
likely to evolve to AD [42].
As for the second point of concern, controversial datawere
obtained particularly in studies that relied on manual versus
automated segmentation methods. Automated methods used
geometric rules as the criteria for defining subfields, whereas
manual segmentation and 3D surface reconstruction methods
used anatomical points derived from central nervous system
atlases (e.g., [8]). Indeed, there were differences in defining
the CA1 and subiculum in previous studies. For example, as
acknowledged by Mueller et al. [34], the border used in that
study was chosen “because it could be easily and reliably
identified although by doing so, parts of the presubiculum
and subiculum proper were counted towards CA1” (p. 45).
The choice of these repere points determined whether a larger
or a smaller portion of the hippocampal formation would be
included in the CA1 or in the contiguous subfields and the
probability of finding a significant volumetric difference be-
tweenHCsandADpatients.We chose to rely on an automated
technique to segment the hippocampal subfields even in order
to evaluate the transferability of the present data to the clinical
context for diagnostic and possibly therapeutic (e.g., drug
effectiveness) purposes. Indeed, although the high-field
MRI technology needed for delineating hippocampal sub-
fields has increased in recent years, imaging studies have
been limited by the fact that manual work was required to
outline the subfield borders. Although automatic procedures
offer comparable results to manual techniques, they are bias
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of data within a relatively brief period of time (i.e., 8–16 sub-
jects per day, depending on the computational power of avail-
able computers).
Before conclusion, some limitations have to be discussed.
First, a critical aspect is the difference in resolution between
our images (1 ! 1 ! 1 mm) and those originally used by
van Leemput et al. [28] (0.38 ! 0.38 ! 0.8). Although
this difference exists, it must be noted that one of the steps
of the segmentation procedure is the interpolation of input
images to the reference ones at 0.38 ! 0.38 ! 0.8 mm.
Thus, the segmentation is carried out with more resolved im-
ages, and the discrepancy between the two resolutions is
minimized. Although we are aware that this step could intro-
duce some biases, it should be outlined that the original MRI
sequence used by van Leemput et al. [28] was about 35 mi-
nutes long. This makes it useless in clinical settings, espe-
cially in the framework of degenerative diseases, given its
unfitness for patients and its proneness to movement arti-
facts.
Second, the choice to include exclusively amnestic MCI
deserves some comments. In fact, on one side, it was aimed
at constituting a samplewith characteristics as homogeneous
as possible, thus avoiding blurring factors due to symptom-
atic heterogeneity. On the other side, the aim of the present
study was to investigate progressive hippocampal atrophy in
the different phases of AD, including the preclinical stages
of the illness, that is, MCI. Most of works support the hy-
pothesis that amnestic subtype of MCI is more likely to sub-
sequently convert to AD [43], although this is still a debated
issue [44]. In addition to this, to further verify the high risk
for the amnestic MCI patients of our sample to be in the pre-
clinical stage of the illness, we investigated the APOE poly-
morphisms in a clinical subsample. In fact, among
individuals that manifest late-onset AD, the ε4 allele is pre-
sent at a two- to threefold higher rate compared to the gen-
eral population, and some studies indicate up to 65% of
clinically diagnosed cases carry at least one ε4 allele [45].
However, not all ε4 carriers develop AD, and not all AD pa-
tients are ε4 carriers; rather, the ε2 allele seems to play a pro-
tective role [45,46]. To note, the risk to male family
members with APOE 3 / 34 is similar to that for the APOE
3 / 3 carriers. As illustrated in Table 1, most of the AD
and MCI subjects of our subsample were 3 / 3 (83% and
59%, respectively) and, to a lesser extent, 3 / 34 carriers
(17% and 38%, respectively), whereas the ε2 allele is absent
but in a subject. These data are quite reassuring about the
fact that the MCI patients included in our study are in the
preclinical stage of AD. Future longitudinal studies will be
definitely informative in supporting or not our results.
In conclusion, our data point to a nonhomogeneous
pattern of atrophy in the hippocampus of AD patients,
with prevalent involvement of the presubicular-
subicular complex from the very early phases of the dis-
ease that is still evident in the most advanced phases.
This finding is consistent with neuropathological obser-vations in AD patients [15,16], and it is likely the
macroscopic expression of the severe degeneration of
fibers in the perforant pathway. An obvious clinical
application of the presently reported data would be to
evaluate the effectiveness of this pattern of regional
hippocampal atrophy in predicting the conversion from
MCI to fully developed clinical AD. To resolve this
issue, further research is needed in larger groups of
patients followed longitudinally for an adequate number
of years.
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1. Systematic review: There is no consensus about
which hippocampal subfields become atrophic
earliest in the course of Alzheimer’s disease (AD)
or which neuropathological change is primarily
implicated in volume reduction.
2. Interpretation: Our data point to a prevalent atrophy
of the presubicular-subicular complex from the
early phases of AD. This could represent the
morphological counterpart of the functional isolation
of the hippocampus from both the afferent and
efferent neural inputs that underlie the declarative
memory loss in individuals with AD.
3. Future directions: An obvious clinical application of
the presently reported data would be to evaluate the
effectiveness of this pattern of regional hippocampal
atrophy in predicting the conversion from MCI to
fully developed clinical AD. To resolve this issue,
further research is needed in larger groups of patients
followed longitudinally for an adequate number of
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